Health Care & Life Sciences » Pharmaceuticals | Benchmark Holdings PLC

Benchmark Holdings PLC | Income Statement

Fiscal year is October-September. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
27,543.00
35,354.00
44,199.00
109,375.00
140,172.00
151,467
Cost of Goods Sold (COGS) incl. D&A
15,550.00
21,986.00
32,470.00
75,170.00
101,131.00
101,843
Gross Income
11,993.00
13,368.00
11,729.00
34,205.00
39,041.00
49,624
SG&A Expense
7,091.00
12,484.00
21,813.00
41,555.00
52,470.00
56,621
EBIT
4,902.00
884.00
10,084.00
7,350.00
13,429.00
6,997
Unusual Expense
94.00
2,131.00
1,494.00
13,091.00
5,705.00
1,686
Non Operating Income/Expense
108.00
60.00
21.00
1,278.00
1,299.00
2,483
Interest Expense
259.00
248.00
34.00
1,192.00
1,960.00
2,432
Pretax Income
4,853.00
1,375.00
11,359.00
22,657.00
8,127.00
13,297
Income Tax
560.00
54.00
396.00
4,038.00
980.00
9,270
Equity in Affiliates
-
-
-
273.00
27.00
362
Consolidated Net Income
4,293.00
1,321.00
11,755.00
18,346.00
7,120.00
4,389
Net Income
4,294.00
1,315.00
11,988.00
18,337.00
7,440.00
5,009
Net Income After Extraordinaries
4,294.00
1,315.00
11,988.00
18,337.00
7,440.00
5,009
Net Income Available to Common
4,294.00
1,315.00
11,988.00
18,337.00
7,440.00
5,009
EPS (Basic)
0.03
0.01
0.06
0.04
0.01
0.01
Basic Shares Outstanding
136,416.80
126,959.00
201,280.00
417,952.00
522,092.00
531,651
EPS (Diluted)
0.03
0.01
0.06
0.04
0.01
0.01
Diluted Shares Outstanding
136,416.80
126,959.00
201,280.00
417,952.00
522,092.00
531,651
EBITDA
6,033.00
2,288.00
5,716.00
9,258.00
9,921.00
17,399
Non-Operating Interest Income
8.00
60.00
274.00
254.00
258.00
301
Minority Interest Expense
1.00
6.00
233.00
9.00
320.00
620

About Benchmark Holdings

View Profile
Address
Benchmark House
Sheffield South Yorkshire S35 1QN
United Kingdom
Employees -
Website http://benchmarkplc.com
Updated 07/08/2019
Benchmark Holdings Plc engages in the provision of applied biotechnology, sustainability research, and other related services to aquaculture, agriculture, and food sector. It operates through the following segments: Animal Health; Genetics; Advanced Animal Nutrition; Corporate; and All Other. The Animal Health Division segment provides veterinary services, environmental services diagnostics and animal health products to global aquaculture, and manufactures licensed veterinary vaccines and vaccine components.